Search research articles
Contact Us
Filters
Showing results (301-310 of 587) with videos related to
Page
of 59
Sort By:
Diabetologia
|
December 21, 2013
Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China
Qian Ren, Xueyao Han, Yong Tang, et al.
BMC Endocrine Disorders
|
August 31, 2022
Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism
Tianqi Liu, Xiuying Zhang, Li Long, et al.
Clinical Therapeutics
|
August 23, 2017
Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Shanshan Wu, Sanbao Chai, Jun Yang, et al.
BMJ Open Diabetes Research & Care
|
October 24, 2019
Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks
Sanbao Chai, Shuqing Yu, Zhirong Yang, et al.
Journal of Diabetes Investigation
|
December 6, 2017
Prevalence, treatment patterns and control rates of metabolic syndrome in a Chinese diabetic population: China Cardiometabolic Registries 3B study
Yali Jing, Ting Hong, Yan Bi, et al.
Acta Diabetologica
|
March 26, 2017
Relationship between healthy lifestyle behaviors and cardiovascular risk factors in Chinese patients with type 2 diabetes mellitus: a subanalysis of the CCMR-3B STUDY
Yuxin Huang, Jihu Li, Xiaolin Zhu, et al.
Diabetes Research and Clinical Practice
|
September 12, 2015
Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
Feng Sun, Shanshan Wu, Shuxia Guo, et al.
Diabetes Technology & Therapeutics
|
November 7, 2014
Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis
Feng Sun, Sanbao Chai, Kai Yu, et al.
Diabetes Technology & Therapeutics
|
November 2, 2017
Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors
Tingting Zhang, Linong Ji, Yan Gao, et al.
BMC Endocrine Disorders
|
January 20, 2022
Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China
Puhong Zhang, Minyuan Chen, Heng Zhang, et al.
Page
of 59
Search research articles
Search
Showing results (301-310 of 587) with videos related to
Sort By:
Page
of 59
Diabetologia
|
December 21, 2013
Search for genetic determinants of sulfonylurea efficacy in type 2 diabetic patients from China
Qian Ren, Xueyao Han, Yong Tang, et al.
BMC Endocrine Disorders
|
August 31, 2022
Clinical evaluation of an automated TSI bridge immunoassay in the diagnosis of Graves' disease and its relationship to the degree of hyperthyroidism
Tianqi Liu, Xiuying Zhang, Li Long, et al.
Clinical Therapeutics
|
August 23, 2017
Gastrointestinal Adverse Events of Dipeptidyl Peptidase 4 Inhibitors in Type 2 Diabetes: A Systematic Review and Network Meta-analysis
Shanshan Wu, Sanbao Chai, Jun Yang, et al.
BMJ Open Diabetes Research & Care
|
October 24, 2019
Effect of incretin-based therapies on cancers of digestive system among 101 595 patients with type 2 diabetes mellitus: a systematic review and network meta-analysis combining 84 trials with a median duration of 30 weeks
Sanbao Chai, Shuqing Yu, Zhirong Yang, et al.
Journal of Diabetes Investigation
|
December 6, 2017
Prevalence, treatment patterns and control rates of metabolic syndrome in a Chinese diabetic population: China Cardiometabolic Registries 3B study
Yali Jing, Ting Hong, Yan Bi, et al.
Acta Diabetologica
|
March 26, 2017
Relationship between healthy lifestyle behaviors and cardiovascular risk factors in Chinese patients with type 2 diabetes mellitus: a subanalysis of the CCMR-3B STUDY
Yuxin Huang, Jihu Li, Xiaolin Zhu, et al.
Diabetes Research and Clinical Practice
|
September 12, 2015
Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis
Feng Sun, Shanshan Wu, Shuxia Guo, et al.
Diabetes Technology & Therapeutics
|
November 7, 2014
Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis
Feng Sun, Sanbao Chai, Kai Yu, et al.
Diabetes Technology & Therapeutics
|
November 2, 2017
Observational Registry of Basal Insulin Treatment in Patients with Type 2 Diabetes in China: Safety and Hypoglycemia Predictors
Tingting Zhang, Linong Ji, Yan Gao, et al.
BMC Endocrine Disorders
|
January 20, 2022
Effectiveness and safety of basal insulin therapy in type 2 diabetes mellitus patients with or without metformin observed in a national cohort in China
Puhong Zhang, Minyuan Chen, Heng Zhang, et al.
Page
of 59